About 12 Trademarks found that are owned by Affinia Therapeutics Inc.

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

The mark consists of a stylized incomplete diamond with three broken horizontal lines within it, forming a stylized helix.

The mark consists of a stylized incomplete diamond with three broken horizontal lines within it, forming a stylized helix.

Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for medical and clinical gene therapy purposes; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Research and development of pharmaceutical injectables and preparations, namely, vectors and preparations for gene therapy; provision of scientific research information in the field of adeno-associated virus (AAV) vectors and preparations for gene therapy; engineering services to develop vectors and gene therapy products; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Licensing of library of adeno-associated virus (AAV) vectors, protein sequences, nucleic acid sequences, and viral capsids for use in the research and development of gene therapy products and treatment; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

The mark consists of three broken parallel horizontal lines in a diamond shape.

Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system; biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system